Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Net Margin: 2009-2025

Historic Net Margin for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -34.42%.

  • Lifecore Biomedical's Net Margin rose 1308.00% to -5.62% in Q2 2025 from the same period last year, while for May 2025 it was -34.42%, marking a year-over-year decrease of 3415.00%. This contributed to the annual value of -34.42% for FY2025, which is 4379.00% down from last year.
  • Lifecore Biomedical's Net Margin amounted to -34.42% in FY2025, which was down 467.52% from 9.37% recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Net Margin ranged from a high of 9.37% in FY2024 and a low of -91.61% during FY2022.
  • For the 3-year period, Lifecore Biomedical's Net Margin averaged around -19.75%, with its median value being -34.21% (2023).
  • In the last 5 years, Lifecore Biomedical's Net Margin slumped by 8,141bps in 2022 and then spiked by 5,740bps in 2023.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Net Margin stood at -10.20% in 2021, then plummeted by 8,141bps to -91.61% in 2022, then skyrocketed by 5,740bps to -34.21% in 2023, then spiked by 4,357bps to 9.37% in 2024, then crashed by 4,379bps to -34.42% in 2025.